Pear Therapeutics
Boston
About Pear Therapeutics
Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. The company's platform combines novel digital interventions with drugs to enhance efficacy well beyond anything that is commercially available or in clinical development, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective services for payors.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Estimated revenue: $10K – $50K
- Total funding: $409.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Dec 2021)
- Ticker: otcpink:PEARQ
- Website: peartherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, mHealth, Pharmaceutical, Software, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/pear-therapeutics-129186 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.